Imidapril

DB11783InvestigationalSmall molecule

Imidapril is an ACE inhibitor used in the treatment of essential hypertension. Imidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant.

Mechanism: Pharmacologically active on Angiotensin-converting enzyme
Curator reviewed
Formula / weight: C₂₀H₂₇N₃O₆ · 405.4449 g/mol (avg)

Resolves to

Compound

UNIIBW7H1TJS22CAS89371-37-9ChEMBLCHEMBL317094ChEBI135654PubChem5464343

Clinical / RWD

RxNorm60245ATCC09AA16PharmGKBPA452640

Structure

InChIKeyKLZWOWYOHUKJIG-BPUTZDHNSA-NSMILES[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(=O)OCC)C(=O)N1C(=O)N(C)C[C@@]1([H])C(O)=O

Targets

P12821ACE

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

865Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

35Marketed productsAcross 7 countries and 8 labellers

1ATC codeIncluding every combination product, plus 10 drug categories

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Imidapril, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account